| Steffani Citak, APRN | |
|
800 Goodlette Rd Ste 340, Naples, FL 34102-5412 | |
| (239) 206-1625 | |
| (239) 214-8838 |
| Full Name | Steffani Citak |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 800 Goodlette Rd Ste 340, Naples, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023769452 | NPI | - | NPPES |
| APRN11017488 | Other | FL | APRN LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN11017488 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Millennium Home Care Llc | Port charlotte, FL | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physiotherapy Associates Inc | 3577470442 | 429 |
| Millennium Physician Group Llc | 9830244433 | 781 |
News Archive
As emergency response teams in the region scramble to acquire dwindling medical supplies to combat the surge in COVID-19 (coronavirus) infections, diverse members of the New Jersey Institute of Technology community - from engineers to physicists to advanced manufacturing specialists to students - are designing and fabricating devices to help address the shortfall.
Babies born past their due dates – at 42 weeks or later, are at increased risk for cerebral palsy compared to those born at 40 weeks, according to new research. That said, the actual risk of cerebral palsy remains low. According to the CDC one in 303 children have some type of cerebral palsy. Common symptoms may include movement problems, muscle stiffness, poor muscle tone, and spasticity. The symptoms are thought to result from injury to the brain as a fetus or early in infancy.
FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports.
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced the FDA acceptance of its New Drug Application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection device, for which the proposed indications are rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis.
› Verified 3 days ago
| Entity Name | Millennium Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811122880 PECOS PAC ID: 9830244433 Enrollment ID: O20090903000338 |
News Archive
As emergency response teams in the region scramble to acquire dwindling medical supplies to combat the surge in COVID-19 (coronavirus) infections, diverse members of the New Jersey Institute of Technology community - from engineers to physicists to advanced manufacturing specialists to students - are designing and fabricating devices to help address the shortfall.
Babies born past their due dates – at 42 weeks or later, are at increased risk for cerebral palsy compared to those born at 40 weeks, according to new research. That said, the actual risk of cerebral palsy remains low. According to the CDC one in 303 children have some type of cerebral palsy. Common symptoms may include movement problems, muscle stiffness, poor muscle tone, and spasticity. The symptoms are thought to result from injury to the brain as a fetus or early in infancy.
FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports.
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced the FDA acceptance of its New Drug Application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection device, for which the proposed indications are rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steffani Citak, APRN 2675 Winkler Ave Fl 2, Fort Myers, FL 33901-9342 Ph: (877) 856-3774 | Steffani Citak, APRN 800 Goodlette Rd Ste 340, Naples, FL 34102-5412 Ph: (239) 206-1625 |
News Archive
As emergency response teams in the region scramble to acquire dwindling medical supplies to combat the surge in COVID-19 (coronavirus) infections, diverse members of the New Jersey Institute of Technology community - from engineers to physicists to advanced manufacturing specialists to students - are designing and fabricating devices to help address the shortfall.
Babies born past their due dates – at 42 weeks or later, are at increased risk for cerebral palsy compared to those born at 40 weeks, according to new research. That said, the actual risk of cerebral palsy remains low. According to the CDC one in 303 children have some type of cerebral palsy. Common symptoms may include movement problems, muscle stiffness, poor muscle tone, and spasticity. The symptoms are thought to result from injury to the brain as a fetus or early in infancy.
FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports.
Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced the FDA acceptance of its New Drug Application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection device, for which the proposed indications are rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis.
› Verified 3 days ago
Kearston Kylie Perfetto, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 800 Goodlette Rd Ste 340, Naples, FL 34102 Phone: 239-206-1625 Fax: 239-214-8838 | |
Ms. Kathleen Mary Giroux-pfister, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6945 Carlisle Ct Bldg D, Naples, FL 34109 Phone: 239-260-5891 Fax: 239-260-5895 | |
Aimee Bermudez, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 350 7th St N, Naples, FL 34102 Phone: 239-624-3997 Fax: 239-624-8101 | |
Octavia Deuschle, APRN PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 365 5th Ave S, Naples, FL 34102 Phone: 239-298-1998 | |
Mrs. Isabel Cristina Hamro, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1285 Creekside Blvd E Unit 102, Naples, FL 34109 Phone: 239-624-8070 | |
Vanessa Marie Rawlings, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1660 Medical Blvd Ste 200, Naples, FL 34110 Phone: 239-566-3434 Fax: 239-566-2143 | |
Mrs. Leticia Aquino Rosado, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5262 Golden Gate Pkwy, Naples, FL 34116 Phone: 239-455-5105 |